PPARGC1A and polycystic ovary syndrome: Moreover, the free androgen index [34], serum AMH level [35–38], PPARGC1A (a leukocyte methylation promoter) [39], and some other indices were also found to be potential biomarkers for predicting PCOS and classifying its phenotypes.